Nexgel Inc (NXGL)
NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx
Aligos Therapeutics (ALGS)
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
Geron Corporation Inc (GERN)
Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
Absci Corporation (ABSI)
Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization
Geron Corp. (GERNW)
Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
Bionano Genomics Inc (BNGO)
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
Xtant Medical Holdings Inc. (XTNT)
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft
Praxis Precisions Medicines Inc (PRAX)
Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026
DexCom Inc (DXCM)
DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM
DexCom Inc (DXCM)
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm